Cannabis pill study for MS-related muscle stiffness
Part of Brain & nervous system, Immune system & allergy clinical trials.
This Phase 2 trial tests whether cannabis can reduce muscle stiffness (spasticity) in people with multiple sclerosis. You may be able to participate if your stiffness is not improving with your current treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with multiple sclerosis for at least 6 months by an MS specialist (neurologist)
- You have MS-related muscle stiffness that has lasted at least 1 month and is not controlled, scoring 4 or higher on a stiffness scale
- Your MS medicines for spasticity have been stable for at least 30 days, and you agree to keep the same doses during the study
- You are age 21 or older and can follow all study instructions
- You can read and speak French or English (at least about grade 9 level)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether cannabis, with either THC or CBD, helps with bladder and urinary symptoms caused by multiple sclerosis. It compares two types of cannabis to see which works better.
This study looks at whether cannabidiol (CBD, a cannabis-related medicine) can improve symptoms in people with multiple sclerosis (MS), especially how sleep and pain type affect outcomes. It’s mainly for people with MS and ongoing moderate-to-severe pain, while carefully checking safety and medication interactions.
This study looks at patterns of muscle stiffness (spasticity) in people with multiple sclerosis and how these patterns affect daily life and well-being. It aims to better understand the link between spasticity and quality of life.
This study tests an investigational drug (BMS-986368) to see if it helps reduce muscle stiffness and spasms caused by multiple sclerosis. It may be an option if you have had spasticity for at least 6 months and are not currently using other treatments that cannot be paused.
This study tests a new extended-release tablet called arbaclofen to see if it helps reduce muscle stiffness and spasms in people with multiple sclerosis (MS). If you join, you'll take the study drug or a placebo (a tablet with no active medicine) and report how your symptoms feel.
This study tests an experimental pill (BMS-986368) that targets two brain chemicals to reduce muscle stiffness after a stroke. It's for people who had a stroke in the last 4 to 18 months and have moderate tightness in their elbow and wrist.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.